DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: The standardization of methods for the diagnosis of autism and genomic tools are fundamental to disentangle the heterogeneous and complex genetic architecture of ASD associated with dystrophin pathogenic variants, most particularly because dystrophinopathies are rare conditions and statistical power to uncover the genetic model underpinning ASD in these cases can only be achieved if consortia or meta-analyses are conducted.